Infection

Treatment with Paxlovid significantly reduced the duration and severity of SARS-CoV-2 infection among high-risk patients while also reducing health care utilization and severe outcomes, according to a study.

WASHINGTON — Patients with inflammatory arthritis who receive rituximab, interleukin-6 inhibition or Janus kinase inhibitors demonstrate higher severe infection risks vs. TNF inhibitors, according to data presented at ACR Convergence 2024.

Patients with autoimmune or inflammatory rheumatic diseases living in rural areas demonstrate a 24% higher mortality risk after SARS-CoV-2 infection vs. those in urban areas, according to data published in Arthritis Care & Research.

The FDA has issued a 510(k) clearance to Imbed Biosciences to market Microlyte Ag/Lidocaine for the management of painful skin wounds, the company announced in a press release.

ORLANDO — Certain Mohs surgery repair types raised the risk for healing complications following adjuvant radiation therapy, according to a presentation at the American Society for Dermatologic Surgery Annual Meeting.

SAN DIEGO — Patients who were hospitalized during the omicron variant wave were less likely to develop AKI compared with patients who had previous waves of SARS-CoV-2 infection, according to data presented at ASN Kidney Week, here.

LOS ANGELES — Paxlovid reduced the risk for severe COVID-19 hospitalization or death among people with existing immunity from a previous infection or vaccination, according to pooled trial data presented at IDWeek.

A 20-month outbreak of multidrug-resistant Enterobacter cloacae in an ICU was associated with the presence of cockroaches, according to a study that linked outbreak strains to strains found in the insects.

SAN ANTONIO — In this video, Grant E. Garrigues, MD, FAAOS, spoke about common considerations for addressing infections in shoulder and elbow surgery such as diagnosis, preparation, prevention, gender differences, antibiotics and revision.